Researchers developed a method to non-invasively mimic the hormonal benefits of bariatric surgery and are preparing to initiate a second trial to show that the hormonal changes lead to improved weight management and glucose control over time.
The SC CTSI provided support for research to study a drug that may ultimately restore cognitive function in patients with Alzheimer’s Disease (AD).
To compare outcomes of two common surgical procedures for children with liver complications due to Alagille syndrome, researcher Kasper Wang, MD, associate professor of surgery, Keck School of Medicine of USC and pediatric surgeon, CHLA is driving a collaborative study with coll…
In a multi-year study, USC researchers are partnering with researchers from around the country to use magnetic resonance imaging (MRI) to understand the long-term effect of statin drugs on the arterial blockages associated with atherosclerosis, the world’s leading cause of death…
Research by Jessica Maria Atrio, MD, former clinical fellow, Keck School of Medicine of USC, demonstrated that a safe but less-frequently prescribed birth control “mini-pill” is effective for women taking human immunodefciency virus (HIV) medications.
Daryl Davies, PhD, associate professor of clinical pharmacy, USC School of Pharmacy, and his collaborators at the University of Southern California (USC) and Children’s Hospital Los Angeles (CHLA) discovered that ivermectin, a drug used to treat parasitic infections in millions …
The SC CTSI helped researchers accelerate the development of a stem cell-based therapy that regenerates gut tissue lost to necrotizing enterocolitis, a complication that can affect prematurely born infants. Pediatric surgeon Tracy Grikscheit, MD, assistant professor of surgery, …
A multidisciplinary team of researchers from the USC Dana and David Dornsife College of Letters, Arts and Sciences and the USC School of Pharmacy demonstrated a way to generate potential new Human Immunodeficiency Virus (HIV) drugs by inhibiting a crucial enzyme in the HIV repli…